TP53BP1 and neoplasm: Females may be better at upregulating compensatory mechanisms to counteract the unrepaired DNA damage (53BP1 upregulation), and therefore are more resistant to negative effects of αSyn loss-of-function in tumor onset and growth phenotypes.